Adverse Events With Fatal Outcome Associated With Alemtuzumab Treatment in Multiple Sclerosis

BMC Research Notes - United Kingdom
doi 10.1186/s13104-019-4507-6
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Correction To: Serious Adverse Events and Fatal Adverse Events Associated With Nivolumab Treatment in Cancer Patients

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2019English

A Case of Autoimmune Myositis After Treatment With Alemtuzumab for Multiple Sclerosis

Multiple Sclerosis Journal - Experimental, Translational and Clinical
2018English

Immune Competence After Alemtuzumab Treatment of Multiple Sclerosis

Neurology
Neurology
2013English

Pnd66 - Cost Effectiveness Analysis of Alemtuzumab as a Treatment Option for Patients With Multiple Sclerosis in Cyprus

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Pnd59 - Cost Effectiveness Analysis of Alemtuzumab as a Treatment Option for Patients With Multiple Sclerosis in Greece

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Practical Management of Adverse Events Associated With Cabozantinib Treatment in Patients With Renal-Cell Carcinoma

OncoTargets and Therapy
OncologyPharmacology
2017English

Pgi1 - Adverse Events Associated With the Treatment of Inflammatory Bowel Disease in Germany

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Nellix Endobag Rupture Associated With a Fatal Outcome

Journal of Vascular Surgery
SurgeryCardiovascular MedicineCardiology
2019English

Hospital Costs Associated With Adverse Events in Gynecological Oncology

Gynecologic Oncology
GynecologyOncologyObstetrics
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy